L-NIL
目录号 : GC36471A selective iNOS inhibitor
Cas No.:53774-63-3
Sample solution is provided at 25 µL, 10mM.
L-NIL is a relatively selective inhibitor of iNOS. It exhibits IC50 values of 0.4-3.3 ?M for iNOS as opposed to 8-38 and 17-92 ?M for eNOS and nNOS, respectively.1,2,3 L-NIL effectively inhibits iNOS both in vitro and in vivo.4,5,3 L-NIL has been used to demonstrate a critical role for iNOS in the immune response to infection by the protozoan L. major.3,6
1.Moore, W.M., Webber, R.K., Jerome, G.M., et al.L-N6-(1-Iminoethyl)lysine: A selective inhibitor of inducible nitric oxide synthaseJ. Med. Chem.373886-3888(1994) 2.Grant, S.K., Green, B.G., Stiffey-Wilusz, J., et al.Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitorsBiochemistry374174-4180(1998) 3.Stenger, S., Thuring, H., Rollinghoff, M., et al.L-N6-(1-iminoethyl)-lysine potently inhibits inducible nitric oxide synthase and is superior to NG-monomethyl-arginine in vitro and in vivoEur. J. Pharmacol.294(2-3)703-712(1995) 4.Budzi?ski, M., Misterek, K., Gumulka, W., et al.Inhibition of inducible nitric oxide synthase in persistent painLife Sci.66301-305(2000) 5.Faraci, W.S., Nagel, A.A., Verdries, K.A., et al.2-Amino-4-methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivoBr. J. Pharmacol.1191101-1108(1996) 6.Diefenbach, A., Schindler, H., Donhauser, N., et al.Type 1 interferon (IFNα/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasiteImmunity8(1)77-87(1998)
Cas No. | 53774-63-3 | SDF | |
Canonical SMILES | N[C@@H](CCCCNC(C)=N)C(O)=O | ||
分子式 | C8H17N3O2 | 分子量 | 187.24 |
溶解度 | Water: 50 mg/mL (267.04 mM); DMSO: < 1 mg/mL (insoluble or slightly soluble) | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 5.3407 mL | 26.7037 mL | 53.4074 mL |
5 mM | 1.0681 mL | 5.3407 mL | 10.6815 mL |
10 mM | 0.5341 mL | 2.6704 mL | 5.3407 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet